Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open-labeled single-blinded randomized controlled trial

Int J Dermatol. 2024 Nov 20. doi: 10.1111/ijd.17572. Online ahead of print.
No abstract available

Keywords: atopic dermatitis; crisaborole; eczema; phosphodiesterase‐4 inhibitor; tacrolimus; topical calcineurin inhibitor.